{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Cutaneous Manifestations of Lupus Erythematosus

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify a subtype of subacute cutaneous lupus erythematosus (SCLE).
  2. Identify features of various forms of lupus erythematosus (LE).
  3. Select a drug that may induce and/or exacerbate SCLE.
  4. Describe the management of a patient with cutaneous LE (CLE).

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of the cutaneous manifestations of lupus erythematosus and the management of a patient with this disease by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $20.00

Credits:

  • ANCC 2.5 CH
  • DC - BON 2.5 CH
  • FL - BON 2.5 CH
  • GA - BON 2.5 CH
  • NM - BON 2.5 CH
  • SC - BON 2.5 CH
  • WV - BOERN 2.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: JDNA0722B
Published: Jul/Aug 2022
Expires: 6/6/2025
Required Passing Score: 8/10 (80%)
Authors: Deepa Ragesh Panikkath, MD; Vaneet Kaur Sandhu, MD, FACR